The successful treatment of IgG4-positive colitis with adalimumab in a patient with IgG4-related sclerosing disease--a new subtype of aggressive colitis? [electronic resource]
- Journal of Crohn's & colitis Apr 2013
- e81-4 p. digital
Publication Type: Case Reports; Journal Article
1876-4479
10.1016/j.crohns.2012.05.003 doi
Adalimumab Adolescent Anti-Inflammatory Agents--therapeutic use Antibodies, Monoclonal, Humanized--therapeutic use Autoimmune Diseases--diagnosis Biomarkers--metabolism Colitis--diagnosis Female Humans Immunoglobulin G--metabolism